Abstract
Purpose: The object of this study was to investigate the antineoplastic action of 5-aza-2′-deoxycytidine (5-AZA) in combination with vitamin D analogs on HL-60 and NB-4 myeloid leukemic cells. The vitamin D analogs chosen for this investigation were 1,25-(OH)2-23-yne-cholecalciferol (23-D) and 1,25-(OH)2-Δ16-23-yne-cholecalciferol (16-23-D) since they have the potential to be used clinically owing to their minimal action on calcium metabolism. Methods: HL-60 and NB-4 leukemic cells were incubated with different concentrations of 5-AZA and either 23-D or 16-23-D and their antineoplastic action determined by inhibition of DNA synthesis and growth, induction of differentiation and colony assay. Results: 5-AZA in combination with either vitamin D analog produced a greater growth inhibition and induction of differentiation than either agent alone. For HL-60 leukemic cells the combination of 5-AZA with either analog produced a synergistic loss of clonogenicity. These effects on clonogenicity correlated with the effects of the combination on inhibition of growth and DNA synthesis. Conclusion: These results suggest that vitamin D analogs may enhance the antileukemic action of 5-AZA and that it may be interesting to test these agents in combination in patients with myeloid leukemia.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 18 February 1997 / Accepted: 3 June 1997
Rights and permissions
About this article
Cite this article
Doré, B., Chomienne, C. & Momparler, R. Effect of 5-aza-2′-deoxycytidine and vitamin D3 analogs on growth and differentiation of human myeloid leukemic cells. Cancer Chemother Pharmacol 41, 275–280 (1998). https://doi.org/10.1007/s002800050740
Issue Date:
DOI: https://doi.org/10.1007/s002800050740